Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
| Report ID | 85554 |
| Drug Identification Number | 02443449 |
| Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
| Common or Proper name | NAPROXEN/ESOMEPRAZOLE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
| Strength(s) | 20MG 500MG |
| Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 60 BT |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-06-19 |
| Actual start date | |
| Estimated end date | 2019-06-30 |
| Actual end date | 2019-06-18 |
| Shortage status | Avoided shortage |
| Updated date | 2019-06-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-06-18 | French | Compare |
| v3 | 2019-06-18 | English | Compare |
| v2 | 2019-06-04 | French | Compare |
| v1 | 2019-06-04 | English | Compare |
Showing 1 to 4 of 4